Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
84°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gritstone Bio Inc
(NQ:
GRTS
)
0.6684
+0.0184 (+2.83%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gritstone Bio Inc
< Previous
1
2
3
4
5
6
Next >
Why Gritstone bio Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
September 28, 2023
Gainers Inpixon (NASDAQ: INPX) shares rose 44.6% to $0.2023 in pre-market trading after gaining around 10% on Wednesday.
Via
Benzinga
Why Is Vaccine Focused Gritstone bio Stock Trading Higher Today?
September 28, 2023
Gritstone Bio Inc (NASDAQ: GRTS) received a contract from the Biomedical Advanced Research and Development Authority (BARDA) to conduct a Phase 2b comparative study evaluating its self-amplifying mRNA...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
September 28, 2023
We're checking out the biggest pre-market stock movers worth watching on Friday with a dive into all of the latest market stories!
Via
InvestorPlace
Gritstone Bio: Q1 Earnings Insights
May 11, 2023
Via
Benzinga
Gritstone Oncology's Return On Capital Employed Overview
March 15, 2023
Via
Benzinga
Earnings Outlook For Gritstone Oncology
March 08, 2023
Via
Benzinga
Gritstone bio Shares Jump After Updated Overall Survival Data From Colorectal Cancer Candidate
November 10, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 27, 2023
Via
Benzinga
Gritstone bio Awarded BARDA Contract to Conduct Comparative Phase 2b Study Evaluating Next-Generation Vaccine Candidate for COVID-19 Valued at up to $433 Million
September 27, 2023
From
Gritstone bio
Via
GlobeNewswire
Cancer Remains Pharma's Biggest Challenge And Mainz Biomed Has The Tool To Help Win The Battle
September 05, 2023
Last week, The European Commission authorizing Comirnaty, a third version of the updated COVID-19 vaccine from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX) to be used in EU countries'...
Via
Benzinga
Exposures
COVID-19
Gritstone bio Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
August 09, 2023
From
Gritstone bio
Via
GlobeNewswire
Gritstone bio Reports First Quarter 2023 Financial Results and Provides Corporate Updates
May 11, 2023
From
Gritstone bio
Via
GlobeNewswire
Moderna, Merck's Cancer Vaccines Exhibit Positive Outcomes Under Midstage Trial
April 17, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023
March 28, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 10, 2023
Via
Benzinga
Gritstone bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Updates
March 09, 2023
From
Gritstone bio
Via
GlobeNewswire
The Next Generation Of Cancer Vaccines Are Coming; What That Means For Moderna And Other Biotech Stocks
February 24, 2023
Startling cancer vaccine results from Moderna may point to the next big thing in biotech.
Via
Investor's Business Daily
Why Planet Labs Shares Are Trading Higher; Here Are 28 Stocks Moving Premarket
December 15, 2022
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares rose 74.7% to $0.4104 in pre-market trading after declining 4% on Wednesday.
Via
Benzinga
Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
December 13, 2022
Gainers OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
Via
Benzinga
InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Announces New Board Member
December 05, 2022
Via
Investor Brand Network
Topics
Artificial Intelligence
Intellectual Property
Exposures
Artificial Intelligence
Intellectual Property
Product Safety
Predictive Oncology Appoints Leading Biopharma Executive Matthew J. Hawryluk Ph.D. to the Board of Directors
December 05, 2022
From
Predictive Oncology Inc.
Via
GlobeNewswire
Why G Medical Innovations Shares Are Trading Lower By 35%; Here Are 25 Stocks Moving Premarket
November 21, 2022
Gainers EUDA Health Holdings Limited (NASDAQ: EUDA) shares rose 88.1% to $8.40 in pre-market trading after merger completed with 8i Acquisition SPAC last week.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
November 21, 2022
We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning!
Via
InvestorPlace
Block To 100? Plus This Analyst Slashes PT On Estée Lauder By 32%
November 07, 2022
Barclays slashed the price target on Block, Inc. (NYSE: SQ) from $130 to $100. Block shares rose 1% to $60.70 in pre-market trading.
Via
Benzinga
Gritstone Reports Third Quarter 2022 Financial Results and Provides Business Update
November 03, 2022
From
Gritstone bio
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 25, 2022
Via
Benzinga
Gritstone Oncology's Return On Capital Employed Overview
August 24, 2022
Benzinga Pro data, Gritstone Oncology (NASDAQ:GRTS) reported Q2 sales of $5.47 million. Earnings fell to a loss of $29.52 million, resulting in a 2.07% decrease from last quarter.
Via
Benzinga
Goldman Sachs Is Bearish On Gritstone Bio: 'Avenues For Financing Are Likely Too Modest'
August 22, 2022
Gritstone bio Inc (NASDAQ: GRTS) has insufficient cash either to reach de-risking catalysts for its lead oncology program, GRANITE, or to support the clinical development of its second program, SLATE,...
Via
Benzinga
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
November 01, 2022
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 31, 2022
October 31, 2022
Upgrades
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.